Visano’s Solution: Targeted Nanobubble Therapy
A New Frontier in Precision Oncology Prostate cancer continues to be one of the most prevalent cancers in men worldwide,
June 21, 2025
More About our technology:
What We Solve and What We Do
Revolutionizing Prostate Cancer Diagnosis and Treatment with Nanobubble Contrast Agents Prostate cancer remains one of the most commonly diagnosed cancers
June 21, 2025
Why Nanobubbles?
VISANO: Revolutionizing Cancer Diagnosis and Treatment with Nanobubbles In the ever-evolving fight against cancer, innovation is crucial. Traditional diagnostic tools
June 21, 2025